Interleukin-1β Attenuates Myofibroblast Formation and Extracellular Matrix Production in Dermal and Lung Fibroblasts Exposed to Transforming Growth Factor-β1
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
One of the most potent pro-fibrotic cytokines is transforming growth factor (TGFβ). TGFβ is involved in the activation of fibroblasts into myofibroblasts, resulting in the hallmark of fibrosis: the pathological accumulation of collagen. Interleukin-1β (IL1β) can influence the severity of fibrosis, however much less is known about the direct effects on fibroblasts. Using lung and dermal fibroblasts, we have investigated the effects of IL1β, TGFβ1, and IL1β in combination with TGFβ1 on myofibroblast formation, collagen synthesis and collagen modification (including prolyl hydroxylase, lysyl hydroxylase and lysyl oxidase), and matrix metalloproteinases (MMPs). We found that IL1β alone has no obvious pro-fibrotic effect on fibroblasts. However, IL1β is able to inhibit the TGFβ1-induced myofibroblast formation as well as collagen synthesis. Glioma-associated oncogene homolog 1 (GLI1), the Hedgehog transcription factor that is involved in the transformation of fibroblasts into myofibroblasts is upregulated by TGFβ1. The addition of IL1β reduced the expression of GLI1 and thereby also indirectly inhibits myofibroblast formation. Other potentially anti-fibrotic effects of IL1β that were observed are the increased levels of MMP1, -2, -9 and -14 produced by fibroblasts exposed to TGFβ1/IL1β in comparison with fibroblasts exposed to TGFβ1 alone. In addition, IL1β decreased the TGFβ1-induced upregulation of lysyl oxidase, an enzyme involved in collagen cross-linking. Furthermore, we found that lung and dermal fibroblasts do not always behave identically towards IL1β. Suppression of COL1A1 by IL1β in the presence of TGFβ1 is more pronounced in lung fibroblasts compared to dermal fibroblasts, whereas a higher upregulation of MMP1 is seen in dermal fibroblasts. The role of IL1β in fibrosis should be reconsidered, and the differences in phenotypical properties of fibroblasts derived from different organs should be taken into account in future anti-fibrotic treatment regimes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interleukin 1 can not only induce, but also inhibit, collagen production, proliferation and myofibroblasts formation in dermal and lung fibroblasts by inhibition of TGFβ signaling (103, 104).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [104]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 1×
“One of the key processes in fibrosis is the activation of fibroblasts into myofibroblasts [13], a”
BackgroundTransforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundDiversity, topographic differentiation, and positional memory in human fibroblasts
Chang, H. Y., Chi, J.-T., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162488599 · Cited by 1,151 · cited 2×
“This difference in behaviour between dermal and lung fibroblasts is in line with the observation (albeit widely neglected) that fibroblasts derived from different organs show major differences in phenotypic properties, as reflected by huge differences in gene expression patterns [37,38].”
BackgroundResultSime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundBroekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753 · cited 2×
“Like various organ fibrosis, lung and skin fibrosis are mediated by the IL1b [6,7,8].”
BackgroundBleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730 · cited 2×
“Like various organ fibrosis, lung and skin fibrosis are mediated by the IL1b [6,7,8].”
BackgroundSiwik, D. A., Chang, D. L.-F., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1259 · Cited by 517
Anatomic Demarcation by Positional Variation in Fibroblast Gene Expression Programs
Rinn, J. L., Bondre, C., Gladstone, H. B., Brown, P. O., & Chang, H. Y. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020119 · Cited by 504 · cited 2×
“This difference in behaviour between dermal and lung fibroblasts is in line with the observation (albeit widely neglected) that fibroblasts derived from different organs show major differences in phenotypic properties, as reflected by huge differences in gene expression patterns [37,38].”
BackgroundResultGasse, P., Mary, C., Guenon, I., Noulin, N., Charron, S., Schnyder-Candrian, S., Schnyder, B., Akira, S., Quesniaux, V. F. J., Lagente, V., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32285 · Cited by 481 · cited 1×
“Neutralisation or other ways of knocking down of IL1b in vivo results in an attenuation of fibrosis [1,2,3,4,5], whereas increasing the level of IL1b enhances the severity of fibrosis [2,6,7].”
BackgroundIdentification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis
van der Slot, A. J., Zuurmond, A.-M., Bardoel, A. F. J., Wijmenga, C., Pruijs, H. E. H., Sillence, D. O., Brinckmann, J., Abraham, D. J., Black, C. M., Verzijl, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307380200 · Cited by 409 · cited 1×
“Increased levels of PLOD2 are seen in fibrotic conditions [49,50], resulting in the formation of increased levels of pyridinium cross-links at the expense of other cross-links, and making the collagen more difficult to degrade.”
BackgroundSelf-citationTGF-β1-mediated fibroblast–myofibroblast terminal differentiation—the role of smad proteins
Evans, R. A., Tian, Y. A. C., Steadman, R., & Phillips, A. O. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00015-0 · Cited by 398 · cited 1×
“the formation of myofibroblasts out of epithelial and endothelial cells [10,35,36].”
BackgroundInterleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
Bujak, M., Dobaczewski, M., Chatila, K., Mendoza, L. H., Li, N., Reddy, A., & Frangogiannis, N. G. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070974 · Cited by 365 · cited 1×
“Neutralisation or other ways of knocking down of IL1b in vivo results in an attenuation of fibrosis [1,2,3,4,5], whereas increasing the level of IL1b enhances the severity of fibrosis [2,6,7].”
BackgroundDennler, S., André, J., Alexaki, I., Li, A., Magnaldo, T., ten Dijke, P., Wang, X.-J., Verrecchia, F., & Mauviel, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0491 · Cited by 342 · cited 2×
“Given the fact that GLI1 is required for the differentiation of fibroblasts into myofibroblasts [12,14,43], we tested whether the attenuation by IL1b of TGFb1-induced activation of fibroblasts is indeed paralleled by decreased levels of GLI1.”
BackgroundLazard, D., Sastre, X., Frid, M. G., Glukhova, M. A., Thiery, J. P., & Koteliansky, V. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.999 · Cited by 334 · cited 1×
“contrast to fibroblasts, extensive cytoplasmic stress fibers with alpha smooth muscle actin (aSMA) and smooth muscle protein 22alpha (SM22a) as its components [40,41,42].”
BackgroundThe role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307 · cited 1×
“In this context it is of interest, that a single injection of an IL1b inhibitor immediately after ligation in a nonreperfused infarction model attenuated the collagen accumulation in the infarcted area [74], indicating that the timing and duration of intervention with regard to IL1b is a key determinant of outcome [75…”
BackgroundKamari, Y., Shaish, A., Vax, E., Shemesh, S., Kandel-Kfir, M., Arbel, Y., Olteanu, S., Barshack, I., Dotan, S., Voronov, E., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.048 · Cited by 287 · cited 1×
“Neutralisation or other ways of knocking down of IL1b in vivo results in an attenuation of fibrosis [1,2,3,4,5], whereas increasing the level of IL1b enhances the severity of fibrosis [2,6,7].”
BackgroundHedgehog Controls Hepatic Stellate Cell Fate by Regulating Metabolism
Chen, Y., Choi, S. S., Michelotti, G. A., Chan, I. S., Swiderska-Syn, M., Karaca, G. F., Xie, G., Moylan, C. A., Garibaldi, F., Premont, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.115 · Cited by 282 · cited 2×
“Pharmacological inhibition of the SHH pathway results in an attenuation of fibrosis in a variety of in vivo models, namely unilateral ureteral obstruction (UUO) [67], systemic sclerosis [68] and liver cirrhosis [66,69,70], although others did not report improvements [71,72].”
BackgroundInterleukin-1 participates in the progression from liver injury to fibrosis
Gieling, R. G., Wallace, K., & Han, Y.-P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90564.2008 · Cited by 281 · cited 1×
“Neutralisation or other ways of knocking down of IL1b in vivo results in an attenuation of fibrosis [1,2,3,4,5], whereas increasing the level of IL1b enhances the severity of fibrosis [2,6,7].”
BackgroundCell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling
Gabbiani, G., & Hinz, B. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-05-0328 · Cited by 258 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundMaleszewska, M., Moonen, J.-R. A. J., Huijkman, N., van de Sluis, B., Krenning, G., & Harmsen, M. C. (2013) · Immunobiology · doi:10.1016/j.imbio.2012.05.026 · Cited by 220
Choi, S. S., Omenetti, A., Witek, R. P., Moylan, C. A., Syn, W.-K., Jung, Y., Yang, L., Sudan, D. L., Sicklick, J. K., Michelotti, G. A., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00292.2009 · Cited by 219 · cited 1×
“As with fibroblasts, activation of the SHH pathway results in the transdifferentiation of hepatic stellate cells into myofibroblasts, a key mechanism in liver fibrosis [63,64,65,66].”
BackgroundGuy, C. D., Suzuki, A., Zdanowicz, M., Abdelmalek, M. F., Burchette, J., Unalp, A., & Diehl, A. M. (2012) · Hepatology · doi:10.1002/hep.25559 · Cited by 218 · cited 1×
“It has been shown that the SHH pathway is activated in fibrotic conditions [60,61,62], that GLI1 expression is induced by TGFb1, and the transformation of fibroblasts into myofibroblasts is GLI1-dependent [14,43].”
Backgroundvan der Slot, A. J., Zuurmond, A.-M., van den Bogaerdt, A. J., Ulrich, M. M. W., Middelkoop, E., Boers, W., Karel Ronday, H., DeGroot, J., Huizinga, T. W. J., & Bank, R. A. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.06.001 · Cited by 216 · cited 1×
“Increased levels of PLOD2 are seen in fibrotic conditions [49,50], resulting in the formation of increased levels of pyridinium cross-links at the expense of other cross-links, and making the collagen more difficult to degrade.”
BackgroundSelf-citationSmoothened is a master regulator of adult liver repair
Michelotti, G. A., Xie, G., Swiderska, M., Choi, S. S., Karaca, G., Krüger, L., Premont, R., Yang, L., Syn, W.-K., Metzger, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66904 · Cited by 208 · cited 1×
“It has been shown that the SHH pathway is activated in fibrotic conditions [60,61,62], that GLI1 expression is induced by TGFb1, and the transformation of fibroblasts into myofibroblasts is GLI1-dependent [14,43].”
BackgroundHedgehog-Gli Pathway Activation during Kidney Fibrosis
Fabian, S. L., Penchev, R. R., St-Jacques, B., Rao, A. N., Sipilä, P., West, K. A., McMahon, A. P., & Humphreys, B. D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.12.039 · Cited by 205 · cited 1×
“Pharmacological inhibition of the SHH pathway results in an attenuation of fibrosis in a variety of in vivo models, namely unilateral ureteral obstruction (UUO) [67], systemic sclerosis [68] and liver cirrhosis [66,69,70], although others did not report improvements [71,72].”
BackgroundSonic Hedgehog Signaling Mediates Epithelial–Mesenchymal Communication and Promotes Renal Fibrosis
Ding, H., Zhou, D., Hao, S., Zhou, L., He, W., Nie, J., Hou, F. F., & Liu, Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060614 · Cited by 198 · cited 1×
“Pharmacological inhibition of the SHH pathway results in an attenuation of fibrosis in a variety of in vivo models, namely unilateral ureteral obstruction (UUO) [67], systemic sclerosis [68] and liver cirrhosis [66,69,70], although others did not report improvements [71,72].”
BackgroundHwang, M., Matsumori, A., Furukawa, Y., Ono, K., Okada, M., Iwasaki, A., Hara, M., Miyamoto, T., Touma, M., & Sasayama, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01591-1 · Cited by 175
Choi, S. S., Syn, W.-K., Karaca, G. F., Omenetti, A., Moylan, C. A., Witek, R. P., Agboola, K. M., Jung, Y., Michelotti, G. A., & Diehl, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168542 · Cited by 174 · cited 1×
“As with fibroblasts, activation of the SHH pathway results in the transdifferentiation of hepatic stellate cells into myofibroblasts, a key mechanism in liver fibrosis [63,64,65,66].”
BackgroundPirfenidone inhibits the expression of HSP47 in TGF-β1-stimulated human lung fibroblasts
Nakayama, S., Mukae, H., Sakamoto, N., Kakugawa, T., Yoshioka, S., Soda, H., Oku, H., Urata, Y., Kondo, T., Kubota, H., et al. (2008) · Life Sciences · doi:10.1016/j.lfs.2007.11.003 · Cited by 165 · cited 1×
“TGFb1 has been reported to induce accumulation of collagen type I [19,45,46,47].”
BackgroundPhilips, G. M., Chan, I. S., Swiderska, M., Schroder, V. T., Guy, C., Karaca, G. F., Moylan, C., Venkatraman, T., Feuerlein, S., Syn, W.-K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023943 · Cited by 165 · cited 1×
“Pharmacological inhibition of the SHH pathway results in an attenuation of fibrosis in a variety of in vivo models, namely unilateral ureteral obstruction (UUO) [67], systemic sclerosis [68] and liver cirrhosis [66,69,70], although others did not report improvements [71,72].”
BackgroundRole of Sonic Hedgehog in idiopathic pulmonary fibrosis
Bolaños, A. L., Milla, C. M., Lira, J. C., Ramírez, R., Checa, M., Barrera, L., García-Alvarez, J., Carbajal, V., Becerril, C., Gaxiola, M., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00184.2012 · Cited by 160 · cited 1×
“respect to the transcription factor GLI1 [11,12,14].”
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Horn, A., Palumbo, K., Cordazzo, C., Dees, C., Akhmetshina, A., Tomcik, M., Zerr, P., Avouac, J., Gusinde, J., Zwerina, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34444 · Cited by 160 · cited 2×
“Given the fact that GLI1 is required for the differentiation of fibroblasts into myofibroblasts [12,14,43], we tested whether the attenuation by IL1b of TGFb1-induced activation of fibroblasts is indeed paralleled by decreased levels of GLI1.”
BackgroundThe type of collagen cross-link determines the reversibility of experimental skin fibrosis.
van der Slot-Verhoeven, A. J., van Dura, E. A., Attema, J., Blauw, B., DeGroot, J., Huizinga, T., Zuurmond, A., & Bank, R. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2005.02.007 · Cited by 155 · cited 1×
“and seem to be associated with its irreversibility [53,54].”
BackgroundSelf-citationCigna, N., Moshai, E. F., Brayer, S., Marchal-Sommé, J., Wémeau-Stervinou, L., Fabre, A., Mal, H., Lesèche, G., Dehoux, M., Soler, P., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.019 · Cited by 154 · cited 5×
“It has been shown that the SHH pathway is activated in fibrotic conditions [60,61,62], that GLI1 expression is induced by TGFb1, and the transformation of fibroblasts into myofibroblasts is GLI1-dependent [14,43].”
BackgroundInfluentialStrategies for prevention of scars: what can we learn from fetal skin?
Namazi, M. R., Fallahzadeh, M. K., & Schwartz, R. A. (2011) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04678.x · Cited by 145 · cited 1×
“Interestingly, an increased collagen III:I ratio is often found in situations where a scarless healing is observed [73].”
BackgroundHisatomi, K., Mukae, H., Sakamoto, N., Ishimatsu, Y., Kakugawa, T., Hara, S., Fujita, H., Nakamichi, S., Oku, H., Urata, Y., et al. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-24 · Cited by 142 · cited 1×
“TGFb1 has been reported to induce accumulation of collagen type I [19,45,46,47].”
BackgroundDiverse biological functions of extracellular collagen processing enzymes
Trackman, P. C. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20605 · Cited by 134 · cited 7×
“The consensus is that myofibroblasts are ultimately responsible for the excessive deposition of ECM in fibrosis.”
BackgroundInfluentialMoon, D., Kim, M.-O., Choi, Y. H., Park, Y.-M., & Kim, G. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.02.011 · Cited by 133
Lawrance, I. C., Maxwell, L., & Doe, W. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00008 · Cited by 126 · cited 1×
“synthesis have been reported [29,30,31], but also opposite data [22,26,27], or no changes at all have been published [32,33,34].”
Guo, J., Gu, N.-L., Chen, J., Shi, T., Zhou, Y., Rong, Y., Zhou, T., Yang, W., Cui, X., & Chen, W. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1063-z · Cited by 124 · cited 1×
“Neutralisation or other ways of knocking down of IL1b in vivo results in an attenuation of fibrosis [1,2,3,4,5], whereas increasing the level of IL1b enhances the severity of fibrosis [2,6,7].”
BackgroundLysyl oxidase in development, aging and pathologies of the skin
Szauter, K. M., Cao, T., Boyd, C. D., & Csiszár, K. (2005) · Pathologie Biologie · doi:10.1016/j.patbio.2004.12.033 · Cited by 122
The role of Hedgehog signaling in fibrogenic liver repair
Choi, S. S., Omenetti, A., Syn, W.-K., & Diehl, A. M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.015 · Cited by 118 · cited 1×
“As with fibroblasts, activation of the SHH pathway results in the transdifferentiation of hepatic stellate cells into myofibroblasts, a key mechanism in liver fibrosis [63,64,65,66].”
BackgroundChaudhuri, V., Zhou, L., & Karasek, M. (2007) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2006.00584.x · Cited by 117 · cited 1×
“Like various organ fibrosis, lung and skin fibrosis are mediated by the IL1b [6,7,8].”
BackgroundMori, Y., Ishida, W., Bhattacharyya, S., Li, Y., Platanias, L. C., & Varga, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20658 · Cited by 111 · cited 1×
“TGFb1 has been reported to induce accumulation of collagen type I [19,45,46,47].”
BackgroundThampatty, B. P., Li, H., Im, H., & Wang, J. H. (2006) · Gene · doi:10.1016/j.gene.2006.08.027 · Cited by 108
Vesey, D. A., Cheung, C. W. Y., Cuttle, L., Endre, Z. H., Gobe, G. C., & Johnson, D. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00401.x · Cited by 108
Desmoulière, A., & Gabbiani, G. (1994) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970290302 · Cited by 107 · cited 1×
“contrast to fibroblasts, extensive cytoplasmic stress fibers with alpha smooth muscle actin (aSMA) and smooth muscle protein 22alpha (SM22a) as its components [40,41,42].”
Backgroundvan der Slot, A. J., van Dura, E. A., de Wit, E. C., DeGroot, J., Huizinga, T. W. J., Bank, R. A., & Zuurmond, A.-M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.009 · Cited by 104 · cited 1×
“TGFb1 is able to stimulate the expression of the mentioned enzymes [52].”
BackgroundSelf-citationVesey, D. A., Cheung, C., Cuttle, L., Endre, Z., Gobe, G., & Johnson, D. W. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.128468 · Cited by 97
Kagan, H. M. (2000) · Acta Tropica · doi:10.1016/s0001-706x(00)00128-5 · Cited by 97 · cited 1×
“Lowering lysyl oxidase activity levels has antifibrotic effects [58,59].”
BackgroundHorn, A., Kireva, T., Palumbo‐Zerr, K., Dees, C., Tomčík, M., Cordazzo, C., Zerr, P., Akhmetshina, A., Ruat, M., Distler, O., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200883 · Cited by 89
Ishida, W., Mori, Y., Lakos, G., Sun, L., Shan, F., Bowes, S., Josiah, S., Lee, W., Singh, J., Ling, L. E., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700303 · Cited by 88
Modulation of Fibroblastic Cytoskeletal Features during Wound Healing and Fibrosis
Gabbiani, G. (1994) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80988-x · Cited by 80
Shimokawa, T., Tostar, U., Lauth, M., Palaniswamy, R., Kasper, M., Toftgård, R., & Zaphiropoulos, P. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800299200 · Cited by 78 · cited 1×
“Recently, an isoform of GLI1, named GLI1DN, has been identified [44].”
BackgroundHedgehog Signaling in Neonatal and Adult Lung
Liu, L., Kugler, M. C., Loomis, C. A., Samdani, R., Zhao, Z., Chen, G. J., Brandt, J. P., Brownell, I., Joyner, A. L., Rom, W. N., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0347oc · Cited by 77 · cited 1×
“Pharmacological inhibition of the SHH pathway results in an attenuation of fibrosis in a variety of in vivo models, namely unilateral ureteral obstruction (UUO) [67], systemic sclerosis [68] and liver cirrhosis [66,69,70], although others did not report improvements [71,72].”
BackgroundMirastschijski, U., Schnabel, R., Claes, J., Schneider, W., Ågren, M. S., Haaksma, C. J., & Tomasek, J. J. (2010) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00574.x · Cited by 75 · cited 1×
“tissue inhibitor of matrix metalloproteinase 1 and 22) [21].”
BackgroundBrinckmann, J., Kim, S., Wu, J., Reinhardt, D. P., Batmunkh, C., Metzen, E., Notbohm, H., Bank, R. A., Krieg, T. M., & Hunzelmann, N. (2005) · Matrix Biology · doi:10.1016/j.matbio.2005.07.002 · Cited by 71 · cited 1×
“and seem to be associated with its irreversibility [53,54].”
BackgroundSelf-citationHedgehog pathway and pediatric nonalcoholic fatty liver disease
Swiderska-Syn, M., Suzuki, A., Guy, C. D., Schwimmer, J. B., Abdelmalek, M. F., Lavine, J. E., & Diehl, A. M. (2013) · Hepatology · doi:10.1002/hep.26230 · Cited by 63 · cited 1×
“It has been shown that the SHH pathway is activated in fibrotic conditions [60,61,62], that GLI1 expression is induced by TGFb1, and the transformation of fibroblasts into myofibroblasts is GLI1-dependent [14,43].”
BackgroundCollagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis.
Counts, D. F., Evans, J. N., Dipetrillo, T. A., Sterling, K. M., & Kelley, J. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32860-0 · Cited by 59
Li, S., Yang, X., Li, W., Li, J., Su, X., Chen, L., & Yan, G. (2012) · Respiration · doi:10.1159/000340041 · Cited by 56
Dynamic Biomechanical Strain Inhibits IL-1β–induced Inflammation in Vocal Fold Fibroblasts
Branski, R. C., Perera, P., Verdolini, K., Rosen, C. A., Hebda, P. A., & Agarwal, S. (2006) · Journal of Voice · doi:10.1016/j.jvoice.2006.06.005 · Cited by 52 · cited 1×
“synthesis have been reported [29,30,31], but also opposite data [22,26,27], or no changes at all have been published [32,33,34].”
Honda, A., Abe, R., Makino, T., Norisugi, O., Fujita, Y., Watanabe, H., Nishihira, J., Iwakura, Y., Yamagishi, S., Shimizu, H., et al. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.09.007 · Cited by 51
Interleukin-1β Activity and Collagen Synthesis in Human Dental Pulp Fibroblasts
Barkhordar, R. A., Ghani, Q. P., RUSSELL, T., & HUSSAIN, M. (2002) · Journal of Endodontics · doi:10.1097/00004770-200203000-00003 · Cited by 51 · cited 1×
“synthesis have been reported [29,30,31], but also opposite data [22,26,27], or no changes at all have been published [32,33,34].”
Cytokine Regulation of Gingival Fibroblast Lysyl Oxidase, Collagen, and Elastin
Hong, H., & Trackman, P. C. (2002) · Journal of Periodontology · doi:10.1902/jop.2002.73.2.145 · Cited by 47 · cited 1×
“synthesis have been reported [29,30,31], but also opposite data [22,26,27], or no changes at all have been published [32,33,34].”
Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling
Pratap, A., Singh, S., Mundra, V., Yang, N., Panakanti, R., Eason, J. D., & Mahato, R. I. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.719900 · Cited by 43 · cited 1×
“Pharmacological inhibition of the SHH pathway results in an attenuation of fibrosis in a variety of in vivo models, namely unilateral ureteral obstruction (UUO) [67], systemic sclerosis [68] and liver cirrhosis [66,69,70], although others did not report improvements [71,72].”
BackgroundHeino, J., & Heinonen, T. (1990) · Biochemical Journal · doi:10.1042/bj2710827 · Cited by 33 · cited 2×
“Interestingly, about two decades ago it has been reported that IL1b is able to inhibit collagen type I synthesis in fibroblasts that are exposed to TGFb [32], but this potentially anti-fibrotic finding seems to be overlooked.”
BackgroundLu, H., Tseng, C.-C., Lee, Y. H., Li, C., & Wang, L. (2010) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2009.01255.x · Cited by 28 · cited 1×
“synthesis have been reported [29,30,31], but also opposite data [22,26,27], or no changes at all have been published [32,33,34].”
Furuyama, A., Hosokawa, T., & Mochitate, K. (2008) · Matrix Biology · doi:10.1016/j.matbio.2008.02.005 · Cited by 24
Usuki, J., Matsuda, K., Azuma, A., Kudoh, S., & Gemma, A. (2012) · Journal of Nippon Medical School · doi:10.1272/jnms.79.46 · Cited by 21 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundCollagen biosynthesis enzymes in lung tissue and serum of rats with experimental silicosis.
Poole, A., Myllylä, R., Wagner, J. C., & Brown, R. C. D. (1985) · PubMed · Cited by 17
Seth, P., & Yeowell, H. N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27315 · Cited by 15
Xiao, H., Ji, A.-M., Li, Z., Song, X., Su, D., & Chen, A. (2008) · PubMed · Cited by 12
Cited by
Regeneration of Dermis: Scarring and Cells Involved
Rippa, A. L., Kalabusheva, E. P., & Vorotelyak, E. A. (2019) · Cells · doi:10.3390/cells8060607 · Cited by 294
“The search for antifibrotic factors has shown that TGF-β3 suppresses scar formation [164,165]; bFGF (FGF-2) [166–169] and IL-1β [170,171] are suppressors of α-SMA expression and mFB generation, antagonizing the effect of TGF-β1.”
BackgroundOrigin and Consequences of Necroinflammation
Sarhan, M., Land, W. G., Tonnus, W., Hugo, C. P., & Linkermann, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00041.2016 · Cited by 207
Current and upcoming therapies to modulate skin scarring and fibrosis
Coentro, J. Q., Pugliese, E., Hanley, G., Raghunath, M., & Zeugolis, D. I. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.009 · Cited by 204
Molecular and tissue alterations of collagens in fibrosis
Ricard-Blum, S., Baffet, G., & Théret, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.004 · Cited by 173
“synthesis in dermal and lung fibroblasts [74].”
Hodges, P. W., James, G., Blomster, L. V., Hall, L., Schmid, A. B., Shu, C. C., Little, C. B., & Melrose, J. (2015) · Spine · doi:10.1097/brs.0000000000000972 · Cited by 162
Metadata
- Authors
- Mia, M. M., Boersema, M., & Bank, R. A.
- Affiliations
- University Medical Center Groningen (NL)
- Corresponding author
- Bank, Ruud A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-12
- Volume
- 9
- Issue
- 3
- Pages
- e91559
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3951452
- OpenAlex
- W2155540606
- Cited by
- 109
- References
- 76
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 14 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 11 · 2019: 13 · 2018: 11 · 2017: 9 · 2016: 5 · 2015: 13 · 2014: 2
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Funders
- ZonMw (40-00506-98-9021)
- Universitair Medisch Centrum Groningen (40-00506-98-9021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- IL-1β, TGF-β1, myofibroblast differentiation, fibroblast activation, fibrosis, extracellular matrix synthesis, collagen synthesis, Gli1, Hedgehog signaling, matrix metalloproteinases, lysyl oxidase, collagen cross-linking, dermal fibroblasts, lung fibroblasts, COL1A1
- MeSH terms
- Zinc Finger Protein GLI1, Cell Differentiation, Dose-Response Relationship, Drug, Drug Interactions, Extracellular Matrix, Fibroblasts, Humans, Lung, Skin, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Enzymologic, Matrix Metalloproteinases, Collagen Type I, Collagen Type III, Interleukin-1beta, Transforming Growth Factor beta1, Hedgehog Proteins, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.